Search

everythinglearnresearchcommunity

for

Search:↓

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Skin cell types develop when specific genes are turned on by removing certain chemical tags from DNA.

Oral clindamycin and rifampicin are the most effective treatments for Folliculitis decalvans.

A new combination of tadalafil and finasteride improves drug performance and stability.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

The DNS FUE technique offers discreet hair transplants with high satisfaction and low damage rates.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Adalimumab improved folliculitis decalvans in most patients.

PPCM microspheres can effectively release finasteride over 42 days.

It's important to understand the differences between FMF and PFM in children.

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.

Folliculotropic mycosis fungoides can occur in children and is diagnosed with specific tests, but often stays in early stages with treatment.

The Dfl mutation in mice causes poor sebaceous gland function and complete hair loss.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

FGF20 is essential for hair follicle stem cell growth and development in fine-wool sheep.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Systemic photodynamic therapy can effectively treat stubborn folliculitis decalvans with few side effects.

The patient has frontal fibrosing alopecia (FFA).

Dendrobium candidum polysaccharides promote hair growth.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Hair follicle stem cells could lead to new hair loss treatments.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.